申请人:Sankyo Company, Limited
公开号:US05827855A1
公开(公告)日:1998-10-27
Compounds of formula (I): ##STR1## wherein R.sup.1 represents a group of formula (II) or (III): ##STR2## R.sup.2 is alkyl, alkenyl or alkynyl; R.sup.3 and R.sup.4 are each hydrogen, alkyl, alkenyl or alkynyl; R.sup.5 is hydrogen or a carboxy-protecting group; R.sup.a is a group of formula --OR.sup.6 ; R.sup.6 is hydrogen; R.sup.6a and R.sup.6b are each hydrogen, a hydroxy-protecting group, alkyl, alkanesulfonyl, halogenated alkanesulfonyl or arysulfonyl, and their salts and esters. Such compounds inhibit the synthesis of cholesterol, and can be used for the treatment and prophylaxis of hypercholesterolemia and of various cardiac disorders.
化合物的式子(I):##STR1## 其中R.sup.1代表式子(II)或(III)的基团:##STR2## R.sup.2是烷基,烯基或炔基;R.sup.3和R.sup.4分别是氢,烷基,烯基或炔基;R.sup.5是氢或羧基保护基团;R.sup.a是式子--OR.sup.6的基团;R.sup.6是氢;R.sup.6a和R.sup.6b分别是氢,羟基保护基团,烷基,烷基磺酰,卤代烷基磺酰或芳基磺酰,以及它们的盐和酯。这些化合物抑制胆固醇的合成,可用于治疗和预防高胆固醇血症和各种心脏疾病。